Skip to main content
Caplight Logo









AccuPath Group Co., Ltd.

AccuPath Group Co., Ltd.

Private
JiaxingHealthcare & Life Scienceshttps://www.accupathmed.com/

Last Round

Series A

Extension

Oct 25, 2023

Company Overview

AccuPath Group Co., Ltd. is a medical technology company that provides advanced materials, components, and CDMO services for interventional and implantable medical devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturinginterventional medical devicesmedical device componentsballoon cathetersmedical extrusion tubingNitinol componentsimplantable textilesmedical device OEMhypotubesbiocompatible materialsmedical manufacturingmedtech supply chainmedical device prototypingmedical device outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AccuPath Group Co., Ltd. Comparables

Compare AccuPath Group Co., Ltd. with similar companies based on industry and business-model similarity.

AccuPath Group Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomerics
86%
Cirtec Medical
78%
Confluent Medical Technologies
76%

AccuPath Group Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 25, 2023
Pre-A RoundFeb 25, 2022
VC RoundJan 8, 2021

Key People

Founding team and executive leadership

Zhaomin Li

CEO

Executive Team

AccuPath Group Co., Ltd. Investors

Notable investors and investment history

AccuPath Group Co., Ltd. investors
InvestorRounds
Chengwei CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased by 40% MoM.

  • Mar 13, 2025

    Grew 27% QoQ, from 15 to 19 employees.

AccuPath Group Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

AccuPath Group Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersJiaxing
Employee Range19
Year Founded2016
Last FundingOct 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?